| P50 | author | Douglas F Covey | Q87654929 |
| | Vesna Jevtovic-Todorovic | Q60642341 |
| P2093 | author name string | Slobodan M Todorovic | |
| | Sonja L Joksimovic | |
| P2860 | cites work | Hormonal milieu affects tailflick latency in female rats and may be attenuated by access to sucrose | Q67505029 |
| | Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis | Q21145774 |
| | Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease | Q24600153 |
| | Characterization and measurement of dehydroepiandrosterone sulfate in rat brain | Q24633919 |
| | Long-term ovariectomy changes formalin-induced licking in female rats: the role of estrogens | Q24806133 |
| | Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease | Q27334826 |
| | Neuroactive steroids | Q28181775 |
| | Neurosteroids: biochemistry and clinical significance | Q28212390 |
| | The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens | Q28216689 |
| | Neurosteroids: endogenous regulators of the GABA(A) receptor | Q28256904 |
| | Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord | Q28565627 |
| | Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury | Q28567090 |
| | Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia | Q28568886 |
| | Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord | Q28569789 |
| | Neurogenic pain and steroid synthesis in the spinal cord | Q28580830 |
| | Spinal translocator protein (TSPO) modulates pain behavior in rats with CFA-induced monoarthritis | Q28581075 |
| | Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease | Q28740634 |
| | Cellular and Molecular Mechanisms of Pain | Q29011961 |
| | Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors | Q30040470 |
| | Silencing the α2 subunit of γ-aminobutyric acid type A receptors in rat dorsal root ganglia reveals its major role in antinociception posttraumatic nerve injury | Q30279033 |
| | Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone. | Q30371210 |
| | Immunohistological demonstration of CaV3.2 T-type voltage-gated calcium channel expression in soma of dorsal root ganglion neurons and peripheral axons of rat and mouse | Q30410268 |
| | Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons | Q30422994 |
| | 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo | Q30434076 |
| | Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice | Q30434283 |
| | New evidence that both T-type calcium channels and GABAA channels are responsible for the potent peripheral analgesic effects of 5alpha-reduced neuroactive steroids | Q30436316 |
| | 5alpha-reduced neuroactive steroids alleviate thermal and mechanical hyperalgesia in rats with neuropathic pain | Q30437972 |
| | Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. | Q31076606 |
| | Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception | Q33216935 |
| | Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. | Q33537213 |
| | Progesterone prevents nerve injury-induced allodynia and spinal NMDA receptor upregulation in rats. | Q54578185 |
| | A neurosteroid analogue with T-type calcium channel blocking properties is an effective hypnotic, but is not harmful to neonatal rat brain | Q56379822 |
| | Intracellular calcium ions decrease the affinity of the GABA receptor | Q59055224 |
| | A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurones | Q59075458 |
| | LXR and TSPO as new therapeutic targets to increase the levels of neuroactive steroids in the central nervous system of diabetic animals | Q59526281 |
| | Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury | Q60713091 |
| | Modulation of native and recombinant GABAA receptors by endogenous and synthetic neuroactive steroids | Q63488858 |
| | Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody. | Q39170894 |
| | Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy. | Q39709025 |
| | Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis | Q40257452 |
| | Redox modulation of T-type calcium channels in rat peripheral nociceptors | Q40787127 |
| | Sex differences in the perception of noxious experimental stimuli: a meta-analysis. | Q40865293 |
| | Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. | Q40949695 |
| | Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord. | Q42517942 |
| | Membrane progesterone receptors localization in the mouse spinal cord. | Q43212806 |
| | Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3alpha-reduced neurosteroids | Q43270099 |
| | Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems | Q44349079 |
| | Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways | Q44545150 |
| | Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents | Q44758240 |
| | Peripheral nerve injury induces trans-synaptic modification of channels, receptors and signal pathways in rat dorsal spinal cord | Q44791905 |
| | Testosterone affects formalin-induced responses differently in male and female rats | Q44890699 |
| | Analgesic effects and pharmacologic mechanisms of the Gelsemium alkaloid koumine on a rat model of postoperative pain. | Q45070761 |
| | Progesterone reduces the expression of spinal cyclooxygenase-2 and inducible nitric oxide synthase and prevents allodynia in a rat model of central neuropathic pain. | Q47821856 |
| | TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain. | Q48147623 |
| | Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: multi-parametric assessment and direct evidence. | Q48172129 |
| | The induction of pain: an integrative review | Q48284194 |
| | Enantioselective blockade of T-type Ca2+ current in adult rat sensory neurons by a steroid that lacks gamma-aminobutyric acid-modulatory activity | Q48357310 |
| | Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation | Q48706141 |
| | The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors | Q48756725 |
| | Diet and estrous cycle influence pain sensitivity in rats | Q50126336 |
| | Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors | Q33717685 |
| | Neurosteroids: biosynthesis and function of these novel neuromodulators | Q33831306 |
| | Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders | Q33972726 |
| | T-type channels control the opioidergic descending analgesia at the low threshold-spiking GABAergic neurons in the periaqueductal gray | Q34092998 |
| | Selective and differential interactions of BNN27, a novel C17-spiroepoxy steroid derivative, with TrkA receptors, regulating neuronal survival and differentiation | Q34540101 |
| | Descending control of pain | Q34659433 |
| | Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical | Q34895372 |
| | Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. | Q34996330 |
| | Gonadal hormones and sex differences in pain reactivity | Q35147778 |
| | Progesterone synthesis in the nervous system: implications for myelination and myelin repair. | Q35743169 |
| | Progesterone produces antinociceptive and neuroprotective effects in rats with microinjected lysophosphatidic acid in the trigeminal nerve root | Q35860900 |
| | Visceral pain: gender differences in response to experimental and clinical pain | Q35868765 |
| | The role of female gonadal hormones in behavioral sex differences in persistent and chronic pain: clinical versus preclinical studies | Q36197444 |
| | Sex hormones, central nervous system and pain | Q36372686 |
| | The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects | Q36394892 |
| | Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. | Q36562979 |
| | Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection | Q36582899 |
| | Fast synaptic inhibition in spinal sensory processing and pain control | Q36661675 |
| | Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice | Q36768687 |
| | Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis. | Q36871346 |
| | The membrane-associated progesterone-binding protein 25-Dx: expression, cellular localization and up-regulation after brain and spinal cord injuries. | Q36873573 |
| | Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters | Q36995022 |
| | Neuroactive steroids: state of the art and new perspectives. | Q37014232 |
| | Endogenous steroid production in the spinal cord and potential involvement in neuropathic pain modulation. | Q37146861 |
| | Neuropathic pain: a maladaptive response of the nervous system to damage | Q37401775 |
| | Evidence for a key role of steroids in the modulation of pain. | Q37541440 |
| | Neurosteroids: a new brain function? | Q38008829 |
| | Neurosteroids as regenerative agents in the brain: therapeutic implications | Q38084436 |
| | Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions. | Q38130020 |
| | Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. | Q38156547 |
| | Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection | Q38246676 |
| | Neuroactive steroids and the peripheral nervous system: An update. | Q38396464 |
| | An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: involvement of the sigma-1 receptor | Q38483796 |
| | NGF/TrkA Signaling as a Therapeutic Target for Pain | Q38603107 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pain management | Q621261 |
| | pharmacology | Q128406 |
| P304 | page(s) | 1127 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Neurosteroids in Pain Management: A New Perspective on an Old Player | |
| P478 | volume | 9 | |